regorafenib,xl092,atezolizumab
roche,bayer,exelixis
['xl092', 'regorafenib', 'rectal', 'colorectal', 'stellar-303', 'atezo']
also from 8-11 #asco23, s randy hecht, md, presents his poster session titled stellar-303: a phase 3 study of xl092 in combination with atezolizumab versus regorafenib in patients with previously treated metastatic colorectal cancer. hall a. 
We are accelerating discoveries to prevent and cure cancer.